Activmed Practices & Research LLC

1. AbbVie, Inc. $39,294 5 payments
2. EMD Serono, Inc. $38,767 7 payments
3. Adaptive Biotechnologies Corporation $29,165 3 payments
4. Biohaven Pharmaceuticals, Inc. $12,890 8 payments
5. Ge Healthcare $4,632 3 payments
6. Biohaven Pharmaceutical Holding Company Ltd. $921 1 payment
7. Guerbet LLC $132 1 payment

1. A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety $38,767 7 payments
2. ImmuneSense Lyme $29,165 3 payments
3. A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants $21,550 3 payments
4. A Randomized Double-Blind Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder $13,810 9 payments
5. Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) $12,744 1 payment
6. A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone $5,000 1 payment
7. Comparison of Gadolinium Presence in the Brain Following Repeated Administration of Multiple Gadolinium Based $4,500 1 payment
8. Comparison of Gadolinium Presence in the Brain Following Repeated Administration of Multiple Gadolinium-Based $132 2 payments
9. Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY) $132 1 payment

1. Other $29,297 4 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.